This combination is designed to provide synergistic effects on weight loss and glycemic control by targeting both amylin and GLP-1 receptors
The first animal studies showing that GLP-1 potentially had effects on the CV system was published in 2002, and the first study to show cardioprotection was in 2008 (102, 211), but it was not until the LEADER cardiovascular outcomes trial (CVOT) with liraglutide, published in 2016, that a reduction in CV risk with a GLP-1RA was documented (100)
That is why our Doral clinic prescribes CJC-1295/Ipamorelin and does not offer Sermorelin
Anti-inflammatory agents for depression, diabetes and their comorbidity Anti-inflammatory agents for depression and diabetes comorbidity have been explored extensively due to inflammations role in both conditions
doi: 10.1592/phco.29.11.1280 57 BrockCHansenCSKarmisholtJMollerHJJuhlAFarmerADet al
An alternative to injectable BPC 157 is the Pentadeca Arginate Peptide, which offers similar benefits in terms of repair and recovery
